NCT03887104 is a clinical trial of SD-OCT in Eyes Without Ocular Pathology, sponsored by Optovue.

Who is sponsoring NCT03887104?

NCT03887104 is sponsored by Optovue.

What drugs are being tested in NCT03887104?

Interventions in NCT03887104: SD-OCT.

What condition does NCT03887104 study?

NCT03887104 studies Eyes Without Ocular Pathology.

Is NCT03887104 still recruiting?

NCT03887104 is currently completed. Last updated 3 September 2019.

Last reviewed 2019-09-03 · How we verify

NCT03887104

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Data Collection of OCT and OCTA-based Ocular Measurements

Completed Last updated 3 September 2019

What this trial tests

trial testing SD-OCT in Eyes Without Ocular Pathology in 482 participants. Completed in 30 August 2019.

Timeline

8 February 2019

Primary endpoint
11 July 2019

30 August 2019

Quick facts

Lead sponsor	Optovue
Status	Completed
Study type	OBSERVATIONAL
Enrollment	482
Start date	8 February 2019
Primary completion	11 July 2019
Estimated completion	30 August 2019
Sites	5 locations across United States

Drugs / interventions tested

SD-OCT

Conditions studied

Eyes Without Ocular Pathology — all drugs for Eyes Without Ocular Pathology →

Sponsor

Optovue

Who can join

Eligibility, any sex, with Eyes Without Ocular Pathology. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Data Collection of OCT and OCTA-based Ocular Measurements

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of SD-OCT

Trials testing the same drug.

NCT04499703 — Evaluation of the Retinal Health Monitoring System Thickness Module · completed
NCT04161963 — Incidence of Sub-clinical Cystoid Macular Edema After Cataract Surgery · unknown
NCT03852485 — Comparison of OCT and OCTA-based Ocular Measurements to Those of Predicate · completed
NCT03859310 — Precision of OCT and OCTA-based Ocular Measurements · completed
NCT03109665 — Glaucoma Within Northern Ireland Cohort for the Longitudinal Study of Ageing · completed

Other Optovue trials

Trials by the same sponsor.

NCT04437082 — Performance Evaluation of OCT and OCT Angiography-based Ocular Measurements (Optical Coherence Tomography) · completed
NCT03852485 — Comparison of OCT and OCTA-based Ocular Measurements to Those of Predicate · completed
NCT03859310 — Precision of OCT and OCTA-based Ocular Measurements · completed
NCT02911883 — Evaluation of the Repeatability and Reproducibility of AngioVue · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03887104 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Optovue
Last refreshed: 3 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03887104.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing